Notes from the XIV International AIDS Conference in Barcelona, Spain.
Susman
Ed
E
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D000279:Administration, Cutaneous; D000779:Anesthetics, Local / Q000008:administration & dosage; D019380:Anti-HIV Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D001118:Argentina; D001208:Asia / Q000453:epidemiology; D001294:Attitude to Health; D001364:Awareness; D002648:Child; D002662:Child Health Services; D003226:Congresses as Topic; D003906:Developing Countries; D004196:Disease Outbreaks; D000077560:Enfuvirtide; D005260:Female; D015700:HIV Envelope Protein gp41 / Q000627:therapeutic use; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy; D006296:Health Services; D018451:Homosexuality, Male; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use
D000779:Anesthetics, Local; D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D000077560:Enfuvirtide; D008012:Lidocaine